Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Delayed Nasdaq
Other stock markets
 09:39:59 2024-05-13 am EDT 		5-day change 1st Jan Change
0.9056 USD +2.89% Intraday chart for Accelerate Diagnostics, Inc. -1.57% -76.90%
May. 08 Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M MT
May. 08 Transcript : Accelerate Diagnostics, Inc., Q1 2024 Earnings Call, May 08, 2024

Evolution of the average Target Price on Accelerate Diagnostics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4ca34e6a64.qe-jnSEE4L5-_uToYyHtf-yHr1z77TcqywDP3E36Ins.3qHJwlJnt98tqa-nLlikNqvY_CnNgm1Qv2yfsiLLQAvlo-nVa1WujQuqkw~8877adc0d0b62fe391be7e7c656f5b69

Analyst Recommendations on Accelerate Diagnostics, Inc.

Craig Hallum Cuts Accelerate Diagnostics Price Target to $0.60 From $2, Maintains Hold Rating MT
Craig-Hallum Downgrades Accelerate Diagnostics to Hold From Buy; Price Target is $5 MT
Craig-Hallum Adjusts Accelerate Diagnostics' Price Target to $9 from $12, Maintains Buy Rating MT
ACCELERATE DIAGNOSTICS : Piper Sandler Adjusts Price Target on Accelerate Diagnostics to $9 From $12, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8802
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Accelerate Diagnostics, Inc.

Craig-Hallum

Ratings for Accelerate Diagnostics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. Consensus Accelerate Diagnostics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW